New York Blood Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:New York Blood Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9347
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization’s blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical services such as cellular therapy, clinical services, hemophilia services, laboratory services and transfusion medicine services. NYBC’s clinical services include apheresis services, lipoprotein apheresis, autologous platelet rich plasma and bone marrow concentrate, and cell salvage. The organization caters to hospitals and patients. It operates in New York, New Jersey, Hudson Valley, Long Island, Connecticut and Pennsylvania. NYBC is headquartered in New York, the US.

New York Blood Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9
New York Blood Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
New York Blood Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pluristem Therapeutics to Enter into Agreement with New York Blood Center 11
New York Blood Center Enters into Agreement with University of California 12
Community Blood Center Forms Joint Venture with New York Blood Center 13
Cerus Enters Into Co-Development Agreement With New York Blood Center 14
New York Blood Center – Key Competitors 15
New York Blood Center – Key Employees 16
New York Blood Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jun 12, 2017: New York Blood Center Announces New Trustees 18
Government and Public Interest 19
Nov 05, 2018: Celdara Medical and New York Blood Center receive SBIR contract for autoimmune discovery research 19
Oct 16, 2017: New York Blood Center’s Dr. Mohandas Narla Awarded Program Project Grant by the National Institute of Diabetes and Digestive and Kidney Diseases 20
Jun 19, 2017: $3.6 Million NIH Grant Awarded to NYBC Scientist for Research on River Blindness Vaccine 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
New York Blood Center, Pharmaceuticals & Healthcare, Key Facts 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9
New York Blood Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pluristem Therapeutics to Enter into Agreement with New York Blood Center 11
New York Blood Center Enters into Agreement with University of California 12
Community Blood Center Forms Joint Venture with New York Blood Center 13
Cerus Enters Into Co-Development Agreement With New York Blood Center 14
New York Blood Center, Key Competitors 15
New York Blood Center, Key Employees 16
New York Blood Center, Subsidiaries 17

List of Figures
New York Blood Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[New York Blood Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rosehill Resources Inc (ROSE):企業の財務・戦略的SWOT分析
    Rosehill Resources Inc (ROSE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Screen Holdings Co., Ltd. (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • Prospect Medical Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prospect Medical Holdings Inc (PMHI) is a healthcare service provider that offers patient care services. The center offers medical, surgical and psychiatric services, among others. It owns and operates hospitals, clinics and physician networks that offers managed care services for HMO enrole …
  • Taylor Morrison Home Corp:企業の戦略・SWOT・財務分析
    Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report Summary Taylor Morrison Home Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention a …
  • Group 1 Automotive, Inc.:企業の戦略・SWOT・財務情報
    Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Panther Energy Company LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Panther Energy Company LLC (PEC) is an oil and gas company that offers drilling services. The company’s business activities include exploration, acquisition, development and production of oil, natural gas liquids and natural gas. It carries out grassroots horizontal exploration of unconventi …
  • Sarepta Therapeutics Inc (SRPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sarepta Therapeutics Inc (Sarepta) is discovers and develops unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches to treat rare neuromuscular diseases. The company develops drugs based on its proprietary, highly-differentiated and innovative platform technolog …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • Lucigen Corp:企業の製品パイプライン分析2018
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Fletcher Building Ltd:企業のM&A・事業提携・投資動向
    Fletcher Building Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fletcher Building Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Fortune Brands Home & Security Inc:企業の戦略・SWOT・財務分析
    Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report Summary Fortune Brands Home & Security Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • O’Learys Trademark AB:企業の戦略・SWOT・財務分析
    O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report Summary O'Learys Trademark AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clop …
  • Carnival Corporation & plc:企業の戦略・SWOT・財務分析
    Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report Summary Carnival Corporation & plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務情報
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆